Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KH001 in Dentin Hypersensitivity
NCT06464939Phase 2Completed
- Sponsor
- HysensBio
- Start
- Oct 2024
- Primary completion
- Dec 2025
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of KH-001 in dentin hypersensitivity (DH), sponsored by HysensBio. Started Oct 2024; status: completed.
02
Drugs
KH-001
03
Conditions
dentin hypersensitivity (DH)
Beyond the preview
Go deeper on NCT06464939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06464939.